NCT03502681 A Study Combining Eribulin Mesylate With Avelumab in Cisplatin Ineligible Metastatic Urothelial Cell Cancer Patients Status TERMINATED Phase PHASE1
NCT03502616 Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) Status COMPLETED Phase PHASE3
NCT03499353 Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer Status TERMINATED Phase PHASE2
NCT03498378 Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03498196 A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03495791 Educational Intervention to Improve Patient-Physician Awareness of Cardiovascular Risk in Rheumatoid Arthritis. Status COMPLETED Phase NA
NCT03494816 Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion Status COMPLETED Phase PHASE2
NCT03492697 A Single Dose Crossover Study In Healthy Subjects To Evaluate Different Formulations Of PF-06882961 Status COMPLETED Phase PHASE1
NCT03487822 A Personalized Self-Management Program for Older Adults With Chronic Pain and Negative Emotions Status COMPLETED Phase NA
NCT03486457 Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT03478514 Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03472573 Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1
NCT03472560 A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF) Status TERMINATED Phase PHASE2
NCT03469336 Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT03460977 A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma Status RECRUITING Phase PHASE1
NCT03454035 Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors Status RECRUITING Phase PHASE1
NCT03448692 A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS) Status TERMINATED Phase PHASE2